Table 2.
QOL and differences between patients who report and those who do not report an ADE
| Total | Patients not reporting an ADE | Patients reporting ≥1 ADEs | P-value | Effect size d | |
|---|---|---|---|---|---|
| Number of patients | 135 | 98 | 37 | ||
| Mean QOL (SD) | |||||
| Median general QOL score (IQR) | 8.0 (6.0-8.0) | 8.0 (7.0-8.0) | 7.0 (6.0-8.0) | .021† | −0.53 |
| Physical health | 14.9 (2.5) | 15.2 (2.4) | 14.0 (2.6) | .009* | −0.50 |
| Psychological health | 14.7 (2.4) | 15.0 (2.4) | 14.1 (2.5) | .064* | −0.38 |
| Social relationships | 14.5 (2.6) | 14.6 (2.7) | 14.4 (2.6) | .666* | −0.07 |
| Environment | 16.0 (2.2) | 16.2 (2.2) | 15.6 (2.3) | .134* | −0.27 |
QOL = Quality of life; ADE = Adverse drug event; SD = Standard deviation; IQR = Interquartile range.
† = Mann–Whitney U-test; * = T-test.